参考文献:

更新于 2026年10月13日 版权声明
参考文献:

[1]陈伟伟,高润霖,刘力生,等.《中国心血管病报告2016》概要[J].中国循环杂志,2017,32(6):521-530.

[2]Rosselló X,Huo Y,Pocock S,et al.Global geographical variations in ST-segment elevation myocardial infarction management and post-discharge mortality[J].Int J Cardiol,2017,245:27-34.

[3]中华医学会心血管病学分会,中华心血管病杂志编辑委员会.急性ST段抬高型心肌梗死诊断和治疗指南[J].中华心血管病学杂志,2015,43(5):380-393.

[4]O'Gara PT,Kushner FG,Ascheim DD,et al.2013 ACCF/AHA guideline for the management of STelevation myocardial infarction:a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines[J].Circulation,2013,127(4):e362-e425.

[5]Ibanez B,James S,Agewall S,et al.2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation:the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology(ESC)[J].Eur Heart J,2018,39(2):119-177.

[6]罗望胜,向定成,张金霞,等.远程实时传输12导联心电图对急性ST段抬高性心肌梗死患者的院前诊断价值[J].中华急诊医学杂志,2013,22(6):669-673.

[7]段天兵,向定成,秦伟毅,等.建立区域协同救治网络对首诊于非冠状动脉介入治疗医院的急性心肌梗死患者再灌注时间及近期预后的影响[J].中华心血管病杂志,2014,42(8):641-645.

[8]Gibson CM,Pride YB,Buros JL,et al.Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction[J].J Am Coll Cardiol,2008,51(5):546-551.

[9]Widimsky P,Budesínsk T,Vorác D,et al.Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction.Final results of the randomized national multicentre trial--PRAGUE-2[J].Eur Heart J,2003,24(1):94-104.

[10]Pinto DS,Frederick PD,Chakrabarti AK,et al.Benet of transferring ST-segment-elevation myocardial infarction patients for percutaneous coronary intervention compared with administration of onsite brinolytic declines as delays increase[J].Circulation,2011,124(23):2512-2521.(https://www.daowen.com)

[11]佟淑玲.阿替普酶在76例急性心肌梗死溶栓患者治疗中的临床疗效分析[J].中国医药指南,2017,15(6):43-44.

[12]李春洁,李景悦,冯超,等.急性ST段抬高心肌梗死溶栓结合经皮冠状动脉介入治疗研究进展[J].中国介入心脏病学杂志,2017,25(5):293-295.

[13]颜红兵,向定成,刘红梅.ST段抬高型急性心肌梗死院前溶栓治疗中国专家共识-中国医学前沿杂志电子版[J].2018,10(4):1-5.

[14]急性心肌梗死再灌注治疗研究协作组.重组葡激酶与重组组织型纤溶酶原激活剂治疗急性心肌梗死的随机多中心临床试验[J].中华心血管病杂志,2007,35(8):691-696.

[15]Han YL,Liu JN,Jing QM,et al.The efficacy and safety of pharmacoinvasive therapy with prourokinase for acute ST-segment elevation myocardial infarction patients with expected long percutaneous coronary intervention delay[J].Cardiovasc Ther,2013,31(5):285-290.

[16]Berwanger O,Nicolau JC,Carvalho AC,et al.Ticagrelor vs clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial Infarction:a randomized clinical trial[J].JAMA Cardiol,2018.

[17]向定成,于波,苏晞,等.规范化胸痛中心建设与认证[M].北京:人民卫生出版社,2017:9-12,218-226.

[18]国家卫生和计划生育委员会.《胸痛中心建设与管理指导原则》(试行)[EB/OL].2017-10-22.

[19]覃一玲,卢发勇,冯百钧.基于微信平台的急性心肌梗死院前溶栓研究,岭南急诊医学杂志[J].2020,25(3):287-289.

✍AI写作